Prospective comparative study of anesthesia with remimazolam versus conventional methods for TAVR

Prospective comparative study of anesthesia with remimazolam versus conventional methods for TAVR - PROREMIT

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000054251

Enrollment

Registered

2024-09-01

Start date

2024-04-16

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

aortic valve stenosis

Interventions

Selection of anesthesia method Remimazolam protocol Selection of anesthesia method Remimazolam protocol

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 18 years and older With aortic valve stenosis TF-TAVR under MAC Consent can be obtained

Exclusion criteria

Exclusion criteria: Younger than 18 years Non aortic valve stenosis Non-TF TAVR No consent

Design outcomes

Primary

Measure	Time frame
Time to arousal	—

Countries

Japan

Contacts

Public ContactAtsuhiro Kitaura

Kindai University Anesthesiologylogy

anesth@med.kindai.ac.jp0723660221

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026